This compound is a protected nucleoside intermediate featuring a furodioxole core with two benzyl ether groups and a primary alcohol. Its stereochemistry is fully defined, and it is used in the synthesis of modified nucleosides for pharmaceutical research.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Procurando comprar este composto?
Publique um pedido de compra gratuito, sem necessidade de conta. Ele chega aos fornecedores deste produto e as respostas vão direto para o seu e-mail.
3-O-Benzyl-4-(hydroxymethyl)-1,2-O-isopropylidene-a-D-ribofuranose
pharmaceutical intermediate
N-Acetyl-5'-o-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroCytidine
Pharmaceutical intermediate for nucleoside synthesis
((3aR,4R,6R,6aR)-2,2-Dimethyl-6-(2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)tetrahydro-2H-furo(3,4-d)(1,3)dioxol-4-yl)methyl 2-methylpropanoate
Pharmaceutical intermediate for nucleoside synthesis
N-Benzoyl-2'-deoxyadenosine
Pharmaceutical intermediate for nucleoside synthesis
1-Chloro-3,5-Di-O-P-Chlorobenzoyl-2-Deoxy-D-Ribose
Pharmaceutical intermediate for nucleoside synthesis
2-Chloromethyl-4-(3-methoxypropoxy)-3-methylpyridine Hydrochloride
pharmaceutical intermediate
4-(4-Cyclopropyl-1-naphthalenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
pharmaceutical intermediate
Methyl 2-(4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio) acetate
Pharmaceutical intermediate
[(3aR,5R,6S,6aR)-2,2-dimethyl-6-phenylmethoxy-5-(phenylmethoxymethyl)-6,6a-dihydro-3aH-furo[2,3-d][1,3]dioxol-5-yl]methanol
NVBGHWZBQWKVNK-BESBDSHLSA-N
CC1(O[C@@H]2[C@@H]([C@@](O[C@@H]2O1)(CO)COCC3=CC=CC=C3)OCC4=CC=CC=C4)C
—
Procurando comprar este composto?
Publique um pedido de compra gratuito, sem necessidade de conta. Ele chega aos fornecedores deste produto e as respostas vão direto para o seu e-mail.